Praxis Precision Medicines (PRAX) Amortizatization of Intangibles (2020 - 2026)
Praxis Precision Medicines (PRAX) recorded quarterly Amortizatization of Intangibles of $197000.0 in Q1 2026, down 70.64% quarter-over-quarter from $671000.0 in Q4 2025, and down 83.97% on a YoY basis from $1.2 million in Q1 2025.
Praxis Precision Medicines (PRAX) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Praxis Precision Medicines' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $197000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 83.97% year-over-year to $197000.0; the TTM figure through Mar 2026 stood at $2.6 million (up 23.2% YoY), while the FY2025 annual figure was $3.6 million, up 284.99% from the prior year.
- Amortizatization of Intangibles was $197000.0 for Q1 2026 at Praxis Precision Medicines, down from $671000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.0 million in Q3 2024 to a low of -$2.7 million in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged $216000.0 across 5 years, with a median of $197000.0 in 2026.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles sank 303.45% in 2024, then soared 1363.1% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$196000.0 in 2022, then plunged by 239.8% to -$666000.0 in 2023, then tumbled by 303.45% to -$2.7 million in 2024, then soared by 124.97% to $671000.0 in 2025, then sank by 70.64% to $197000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $197000.0 (Q1 2026), $671000.0 (Q4 2025), and $705000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - | 197,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 197,000.00 |
| Mar 31, 2026 | 197,000.00 |
| Dec 31, 2025 | 671,000.00 |
| Dec 31, 2025 | 671,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | -2.69 Mn |
| Dec 31, 2024 | -2.69 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 84,000.00 |
| Mar 31, 2024 | 84,000.00 |
| Dec 31, 2023 | -666,000.00 |
| Dec 31, 2023 | -666,000.00 |